Plastomics, a cutting-edge leader in agricultural biotechnology, today announced the successful initial close of its Series B funding round, securing $5.8 million to fuel the next wave of innovation in crop science. Participating in this round are Fulcrum Global Capital, Lewis & Clark Partners, Skull Diamond and Heart Capital, Missouri Technology Corporation, BioGenerator Ventures, and other premier agfocused investors, signifying strong momentum and broad support for Plastomics’ pioneering chloroplast engineering technology.
This infusion of capital empowers Plastomics to accelerate the development of the world’s
first transgenic traits in the chloroplasts of corn — marking an industry milestone following
the company’s commercial breakthrough in soybean chloroplast transformation. Over the
next 12 to 24 months, Plastomics’ advanced chloroplast trait delivery platform for soybeans
will enter its final commercial phase with upcoming field trials. This milestone will unlock
superior insect and herbicide protection for growers.
“This investment is a powerful validation of our technology and vision,” said Tania Seger, CEO of Plastomics. “In a challenging economic climate, raising close to $6 million from toptier ag-focused investors speaks volumes about their belief in our ability to deliver on this revolutionary science. This Series B funding will accelerate our research and position Plastomics to deliver the first-ever transgenic traits in the chloroplasts of corn.”
Read More – Insignia Capital Group Closes Fund III, at $500M
